Rabies Diagnostics Market Overview

The report is titled ‘Rabies Diagnostics Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the rabies diagnostics market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The rabies diagnostics market is expected to grow at a significant rate in the near future.

The global rabies diagnostics market in 2020 is estimated for more than US$ 1.7 Bn and expected to reach a value of US$ 2.3 Bn by 2028 with a significant CAGR of 4.2%.

Rabies Diagnostics Market Dynamics

Increasing awareness about animal-related diseases is the prime market driving factor. In addition, the factors like the escalating count of awareness programs organized by the government to combat the ill effects of rabies, the necessity of immunization for both humans and animals, healthy surveillance strategies and the development of suitable rabies diagnostics kits also positively impacts the market growth during the forecast years.

Additionally, the initiatives like mass dog vaccinations, adoption of post-exposure prophylaxis (PEP), and the government’s involvement to create appropriate laws linked with the diagnosis of rabies virus also aids the growth of the rabies diagnostics market.

As per the Prevention and Control of Rabies in India’s (APCRI) 2018 journal, India alone counts for approximately 36% of the total deaths due to rabies, followed by China.  Moreover, this country is also recorded to have a maximum count of street dogs, which further propels the demand for rabies diagnostics.

However, the lack of awareness about the technological advancements along with the high cost linked with rabies diagnosis results in restricting the market growth.

On the other hand, the increasing investments for supporting the on-going research activities for the invention of rabies diagnosis kits are expected to create growth opportunities for the market during the upcoming years.

Rabies Diagnostics Market Segmentation

Global rabies diagnostics market is segmented on the basis of diagnostic method, technology, and region.

By Diagnostic Method:

    Fluorescent Antibody Test (FAT)

    Immunohistochemical Test

    Amplification Methods

    Histologic Examination

    Serology Tests

By Technology:

     ELISA/Immunohistochemistry

    Chromatography techniques

    PCR

    Others

By Region:

    North America

    Europe

    Asia Pacific

    Latin America

    Middle East

    Africa

Rabies Diagnostics Market Pipeline Drugs Overview

The global rabies diagnostics market is also influenced by the existing drugs in the pipeline, which accounts for the presence of rAdC68 rabies vaccine that has been tested in non-human primates without pre-existing immunity adenovirus, as per the Wistar Institute. The rAdC68 rabies prophylactic vaccine, developed by the institute is in pipeline and is seeking collaboration to study the final stage development of this vaccine by conducting the clinical trials.

Rabies Diagnostics Market Competitive Landscape

Key players operating in the global rabies diagnostics market include Abbexa Ltd., Aviva Systems Biology Corporation, BioNote, Inc., Bio-Rad Laboratories, Inc., Creative Diagnostics, Demeditec Diagnostics GmbH, Express Biotech International Inc., Merck KGaA, MyBioSource.com, Norgen Biotek Corp., and The Wistar Institute.

Regional Segmentation

On the basis of region, the rabies diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

MMC Overview on Rabies Diagnostics Market Report

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Rabies Diagnostics market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth include (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Rabies Diagnostics

•    Advantages of Rabies Diagnostics

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at a regional level and in major countries globally for providing regional insights into the product segment in the report. This helps our clients to make an informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, its product sales, previous growth rates, and market expansion plans are considered to generate market share in the global market.

1.    Global Rabies Diagnostics Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Rabies Diagnostics Market Overview

2.1.    Introduction

2.1.1.    Market Definition

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Rabies Diagnostics Market Snapshot

2.4.    Global Rabies Diagnostics Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Rabies Diagnostics Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Rabies Diagnostics Market, By Diagnostic Method

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Diagnostic Method

3.1.2.    BPS Analysis, By Diagnostic Method

3.2.    Market Revenue (US$Mn) Forecast, By Diagnostic Method

3.2.1.    Fluorescent Antibody Test (FAT)

3.2.2.    Immunohistochemical Test

3.2.3.    Amplification Methods

3.2.4.    Histologic Examination

3.2.5.    Serology Tests

3.3.    Global Rabies Diagnostics Market Attractiveness Index, By Diagnostic Method

4.    Global Rabies Diagnostics Market, By Technology

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Technology

4.1.2.    BPS Analysis, By Technology

4.2.    Market Revenue (US$Mn) Forecast, By Technology

4.2.1.    ELISA/Immunohistochemistry

4.2.2.    Chromatography Techniques

4.2.3.    PCR

4.2.4.    Others

4.3.    Global Rabies Diagnostics Market Attractiveness Index, By Technology

5.    Global Rabies Diagnostics Market, By Region

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Region

5.1.2.    BPS Analysis, By Region

5.2.    Market Revenue (US$Mn) Forecast, By Region

5.2.1.    North America

5.2.2.    Latin America

5.2.3.    Europe

5.2.4.    Asia Pacific

5.2.5.    Middle East

5.2.6.    Africa

5.3.    Global Rabies Diagnostics Market Attractiveness Index, By Region

6.    North America Rabies Diagnostics Market Analysis and Forecast, 2020–2028

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Country

6.1.2.    BPS Analysis, By Country

6.2.    Market Revenue (US$Mn) Forecast, By Country

6.2.1.    U.S. Rabies Diagnostics Market

6.2.2.    Canada Rabies Diagnostics Market

6.3.    North America Rabies Diagnostics Market, By Diagnostic Method

6.3.1.    Fluorescent Antibody Test (FAT)

6.3.2.    Immunohistochemical Test

6.3.3.    Amplification Methods

6.3.4.    Histologic Examination

6.3.5.    Serology Tests

6.4.    North America Rabies Diagnostics Market, By Technology

6.4.1.    ELISA/Immunohistochemistry

6.4.2.    Chromatography techniques

6.4.3.    PCR

6.4.4.    Others

6.5.    North America Rabies Diagnostics Market Attractiveness Index

6.5.1.    By Country

6.5.2.    By Technology 

6.5.3.    By Diagnostic Method

7.    Latin America Rabies Diagnostics Market Analysis and Forecast, 2020–2028

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market (US$Mn) Forecast, By Country

7.2.1.    Brazil Rabies Diagnostics Market

7.2.2.    Mexico Rabies Diagnostics Market

7.2.3.    Argentina Rabies Diagnostics Market

7.2.4.    Rest of Latin America Rabies Diagnostics Market

7.3.    Latin America Rabies Diagnostics Market, By Diagnostic Method

7.3.1.    Fluorescent Antibody Test (FAT)

7.3.2.    Immunohistochemical Test

7.3.3.    Amplification Methods

7.3.4.    Histologic Examination

7.3.5.    Serology Tests

7.4.    Latin America Rabies Diagnostics Market, By Technology

7.4.1.    ELISA/Immunohistochemistry

7.4.2.    Chromatography techniques

7.4.3.    PCR

7.4.4.    Others

7.5.    Latin America Rabies Diagnostics Market Attractiveness Index

7.5.1.    By Country

7.5.2.    By Technology 

7.5.3.    By Diagnostic Method

8.    Europe Rabies Diagnostics Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    U.K. Rabies Diagnostics Market

8.2.2.    Germany Rabies Diagnostics Market

8.2.3.    Italy Rabies Diagnostics Market

8.2.4.    France Rabies Diagnostics Market

8.2.5.    Spain Rabies Diagnostics Market

8.2.6.    Russia Rabies Diagnostics Market

8.2.7.    Poland Rabies Diagnostics Market

8.2.8.    BENELUX Rabies Diagnostics Market

8.2.9.    NORDIC Rabies Diagnostics Market

8.2.10.    Rest of Europe Rabies Diagnostics Market

8.3.    Europe Rabies Diagnostics Market, By Diagnostic Method

8.3.1.    Fluorescent Antibody Test (FAT)

8.3.2.    Immunohistochemical Test

8.3.3.    Amplification Methods

8.3.4.    Histologic Examination

8.3.5.    Serology Tests

8.4.    Europe Rabies Diagnostics Market, By Technology

8.4.1.    ELISA/Immunohistochemistry

8.4.2.    Chromatography techniques

8.4.3.    PCR

8.4.4.    Others

8.5.    Europe Rabies Diagnostics Market Attractiveness Index

8.5.1.    By Country

8.5.2.    By Technology 

8.5.3.    By Diagnostic Method

9.    Asia Pacific Rabies Diagnostics Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    China Rabies Diagnostics Market

9.2.2.    India Rabies Diagnostics Market

9.2.3.    Japan Rabies Diagnostics Market

9.2.4.    Australia and New Zealand Rabies Diagnostics Market

9.2.5.    South Korea Rabies Diagnostics Market

9.2.6.    ASEAN Rabies Diagnostics Market

9.2.7.    Rest of Asia Pacific Rabies Diagnostics Market

9.3.    Asia Pacific Rabies Diagnostics Market, By Diagnostic Method

9.3.1.    Fluorescent Antibody Test (FAT)

9.3.2.    Immunohistochemical Test

9.3.3.    Amplification Methods

9.3.4.    Histologic Examination

9.3.5.    Serology Tests

9.4.    Asia Pacific Rabies Diagnostics Market, By Technology

9.4.1.    ELISA/Immunohistochemistry

9.4.2.    Chromatography techniques

9.4.3.    PCR

9.4.4.    Others

9.5.    Asia Pacific Rabies Diagnostics Market Attractiveness Index

9.5.1.    By Country

9.5.2.    By Technology 

9.5.3.    By Diagnostic Method

10.    Middle East Rabies Diagnostics Market, By Region

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    GCC Countries Rabies Diagnostics Market

10.2.2.    Israel Rabies Diagnostics Market

10.2.3.    Oman Rabies Diagnostics Market

10.2.4.    Rest of Middle East Rabies Diagnostics Market

10.3.    Middle East Rabies Diagnostics Market, By Diagnostic Method

10.3.1.    Fluorescent Antibody Test (FAT)

10.3.2.    Immunohistochemical Test

10.3.3.    Amplification Methods

10.3.4.    Histologic Examination

10.3.5.    Serology Tests

10.4.    Middle East Rabies Diagnostics Market, By Technology

10.4.1.    ELISA/Immunohistochemistry

10.4.2.    Chromatography techniques

10.4.3.    PCR

10.4.4.    Others

10.5.    Middle East Rabies Diagnostics Market Attractiveness Index

10.5.1.    By Country

10.5.2.    By Technology 

10.5.3.    By Diagnostic Method

11.    Africa Rabies Diagnostics Market, By Region

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    South Africa Rabies Diagnostics Market

11.2.2.    Egypt Rabies Diagnostics Market

11.2.3.    North Africa Rabies Diagnostics Market

11.2.4.    Rest of Africa Rabies Diagnostics Market

11.3.    Africa Rabies Diagnostics Market, By Diagnostic Method

11.3.1.    Fluorescent Antibody Test (FAT)

11.3.2.    Immunohistochemical Test

11.3.3.    Amplification Methods

11.3.4.    Histologic Examination

11.3.5.    Serology Tests

11.4.    Africa Rabies Diagnostics Market, By Technology

11.4.1.    ELISA/Immunohistochemistry

11.4.2.    Chromatography techniques

11.4.3.    PCR

11.4.4.    Others

11.5.    Africa Rabies Diagnostics Market Attractiveness Index

11.5.1.    By Country

11.5.2.    By Technology 

11.5.3.    By Diagnostic Method

12.    Recommendation

12.1.    Market Strategy

13.    Competitive Landscape

13.1.    Competition Dashboard

13.2.    List and Company Overview of Global Key Players

13.3.    Company Profiles

13.3.1.    Abbexa Ltd.

13.3.1.1.    Company Overview

13.3.1.2.    Financial Overview

13.3.1.3.    Product Portfolio

13.3.1.4.    Key Developments

13.3.1.5.    Business Strategies

13.3.2.    Aviva Systems Biology Corporation

13.3.3.    BioNote, Inc.

13.3.4.    Bio-Rad Laboratories, Inc.

13.3.5.    Creative Diagnostics

13.3.6.    Demeditec Diagnostics GmbH

13.3.7.    Express Biotech International Inc.

13.3.8.    Merck KGaA

13.3.9.    MyBioSource.com

13.3.10.    Norgen Biotek Corp.

14.    Acronyms